Home » Topics » Conferences

Conferences
RSS

MMP inhibitors under investigation at Pharmacia & Upjohn

Aug. 27, 1998

News from the ACS: LTB4 antagonists for diagnostic use

Aug. 27, 1998

A-131701: a uroselective alpha-adrenergic agent for treatment of BPH

Aug. 27, 1998

GG-745: a 5alpha-reductase inhibitor with significant advantages over finasteride

Aug. 27, 1998

Selective MMP-3 inhibitor PS-508 described at ACS meeting

Aug. 26, 1998

News from ACS: PD-180988 is a potent and selective ETA antagonist

Aug. 26, 1998

Parke-Davis synthesizes potent and selective D4 ligands with antipsychotic potential

Aug. 26, 1998

ACS news flash: Rhone-Poulenc Rorer studies dual PDE4/MMP inhibitors

Aug. 26, 1998

ACS news flash: R.W. Johnson investigates thrombin inhibitors

Aug. 25, 1998

Lilly describes promising beta3-adrenoceptor agonist at ACS meeting

Aug. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...